UBS Lowers its Price Target on Moelis & Company (MC) to $59 from $74 and Maintains a Neutral Rating

Moelis & Company (NYSE:MC) is one of the 12 Most Undervalued Financial Stocks to Buy Now. On March 12, 2026, Moelis & Company (NYSE:MC) saw UBS lower its price target on the shares to $59 from $74 previously while maintaining a Neutral rating.

Last month, Moelis & Company (NYSE:MC) reported Q4 EPS of $1.13, beating the 83c consensus estimate. Revenue came in at $487.9 million compared with the consensus of $435.1 million. CEO Navid Mahmoodzadegan said the firm delivered “strong momentum” in 2025, supported by what Mahmoodzadegan described as the strongest coverage platform in the company’s history, adding that Moelis enters 2026 positioned to drive further growth and long-term value.

UBS Lowers its Price Target on Moelis & Company (MC) to $59 from $74 and Maintains a Neutral Rating

Moelis & Company (NYSE:MC) operates as an investment banking advisory firm providing services including mergers and acquisitions, recapitalizations, restructurings, capital markets transactions, strategic advisory, capital structure advisory, and private capital advisory across North and South America, Europe, the Middle East, Asia, and Australia.

While we acknowledge the risk and potential of MC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MC and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.